Showing results (71-80 of 1,907) with videos related to

Sort By:
Pageof 191
Folia Biologica|January 30, 2004
Adjuvant cytokine treatment of minimal residual disease after surgical therapy in mice carrying HPV16-associated tumours: cytolytic activity of spleen cells from tumour regressorsM Indrová, R Mikysková, T Jandlová, et al.
Folia Biologica|January 30, 2004
MHC class I+ and class I- HPV16-associated tumours expressing the E7 oncoprotein do not cross-react in immunization/challenge experimentsJ Símová, R Mikysková, V Vonka, et al.
The Journal of General Virology|August 1, 1987
Immunogenicity of a synthetic peptide corresponding to a portion of the heavy chain of H3N2 influenza virus haemagglutininE Hamsíková, H Závadová, M Zaoral, et al.
The Journal of General Virology|February 1, 1990
Presence and type specificity of papillomavirus antibodies demonstrable by immunoelectron microscopy tests in samples from patients with wartsE Anisimová, P Barták, D Vlcek, et al.
The Journal of General Virology|July 1, 1979
Replication of two influenza virus strains and a recombinant in HEF and LEP cellsY Ghendon, E Tucková, V Vonka, et al.
Sexually Transmitted Infections|June 10, 2003
Prospective study on cervical neoplasia: presence of HPV DNA in cytological smears precedes the development of cervical neoplastic lesionsR Tachezy, M Saláková, E Hamsíková, et al.
Epidemiologie, Mikrobiologie, Imunologie : Casopis Spolecnosti Pro Epidemiologii a Mikrobiologii Ceske Lekarske Spolecnosti J.E. Purkyne|March 1, 1995
[Potential carcinogenic factors in cervical intraepithelial neoplasia]J Strauss, A Suchánek, M Krcmár, et al.
Casopis Lekaru Ceskych|December 4, 1992
[Problems associated with the development of vaccines based on recombinant vaccinia virus]L Kutinová, S Nĕmecková, V Ludvíková, et al.
Antiviral Research|August 1, 1990
Properties of a 9-(2-phosphonylmethoxyethyl)adenine (PMEA)-resistant herpes simplex virus type 1 virus mutantV Vonka, E Anisimová, J Cerný, et al.
Folia Biologica|January 7, 2003
Freezing and thawing of murine bone marrow-derived dendritic cells does not alter their immunophenotype and antigen presentation characteristicsL Mendoza, J Bubeník, M Indrová, et al.
Pageof 191